ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
davos97
|
13K |
5.0M |
0 |
24/11/20 |
24/11/20 |
ASX - By Stock
|
13K
|
5.0M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
davos97
|
13K |
5.0M |
23 |
24/11/20 |
24/11/20 |
ASX - By Stock
|
13K
|
5.0M
|
23
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Novartis and Mesoblast Remestemcel-L Collaboration
|
|
davos97
|
811 |
334K |
8 |
23/11/20 |
23/11/20 |
ASX - By Stock
|
811
|
334K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Novartis and Mesoblast Remestemcel-L Collaboration
|
|
davos97
|
811 |
334K |
21 |
23/11/20 |
23/11/20 |
ASX - By Stock
|
811
|
334K
|
21
|
|
ASX - By Stock
|
MSB |
Re:
TYPE A OUTCOME AND NOVARTIS PARTNERSHIP
|
|
davos97
|
111 |
55K |
15 |
23/11/20 |
23/11/20 |
ASX - By Stock
|
111
|
55K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Hart-Scott-Rodino Antitrust Improvements Act
|
|
davos97
|
20 |
7.5K |
16 |
21/11/20 |
21/11/20 |
ASX - By Stock
|
20
|
7.5K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
TYPE A OUTCOME AND NOVARTIS PARTNERSHIP
|
|
davos97
|
111 |
55K |
3 |
20/11/20 |
20/11/20 |
ASX - By Stock
|
111
|
55K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
davos97
|
13K |
5.0M |
5 |
19/11/20 |
19/11/20 |
ASX - By Stock
|
13K
|
5.0M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Pfizer announcement
|
|
davos97
|
127 |
41K |
6 |
19/11/20 |
19/11/20 |
ASX - By Stock
|
127
|
41K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial
|
|
davos97
|
392 |
158K |
9 |
18/11/20 |
18/11/20 |
ASX - By Stock
|
392
|
158K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial
|
|
davos97
|
392 |
158K |
17 |
16/11/20 |
16/11/20 |
ASX - By Stock
|
392
|
158K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
Pfizer announcement
|
|
davos97
|
127 |
41K |
26 |
10/11/20 |
10/11/20 |
ASX - By Stock
|
127
|
41K
|
26
|
|
ASX - By Stock
|
MSB |
Re:
Pfizer announcement
|
|
davos97
|
127 |
41K |
6 |
10/11/20 |
10/11/20 |
ASX - By Stock
|
127
|
41K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Looking forward to the November short squeeze
|
|
davos97
|
106 |
36K |
3 |
07/11/20 |
07/11/20 |
ASX - By Stock
|
106
|
36K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
davos97
|
17K |
6.7M |
8 |
07/11/20 |
07/11/20 |
ASX - By Stock
|
17K
|
6.7M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Archived record of 13 Aug 20 Adcom meet
|
|
davos97
|
5 |
3.9K |
4 |
05/11/20 |
05/11/20 |
ASX - By Stock
|
5
|
3.9K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Archived record of 13 Aug 20 Adcom meet
|
|
davos97
|
5 |
3.9K |
44 |
05/11/20 |
05/11/20 |
ASX - By Stock
|
5
|
3.9K
|
44
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
davos97
|
13K |
5.0M |
35 |
05/11/20 |
05/11/20 |
ASX - By Stock
|
13K
|
5.0M
|
35
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
davos97
|
9.9K |
3.0M |
6 |
02/11/20 |
02/11/20 |
ASX - By Stock
|
9.9K
|
3.0M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Phase 3 DREAM HF-1 read-out
|
|
davos97
|
344 |
180K |
35 |
02/11/20 |
02/11/20 |
ASX - By Stock
|
344
|
180K
|
35
|
|
ASX - By Stock
|
MSB |
Re:
Phase 3 DREAM HF-1 read-out
|
|
davos97
|
344 |
180K |
8 |
01/11/20 |
01/11/20 |
ASX - By Stock
|
344
|
180K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
davos97
|
13K |
5.0M |
31 |
29/10/20 |
29/10/20 |
ASX - By Stock
|
13K
|
5.0M
|
31
|
|
ASX - By Stock
|
MSB |
Re:
MSB - key dates to watch for
|
|
davos97
|
58 |
28K |
18 |
23/10/20 |
23/10/20 |
ASX - By Stock
|
58
|
28K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
Looking forward to the November short squeeze
|
|
davos97
|
106 |
36K |
24 |
23/10/20 |
23/10/20 |
ASX - By Stock
|
106
|
36K
|
24
|
|
ASX - By Stock
|
MSB |
Re:
Gilead's Covid19 Drug Wins Full FDA Approval
|
|
davos97
|
43 |
14K |
11 |
23/10/20 |
23/10/20 |
ASX - By Stock
|
43
|
14K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
The 'American Rule' and speculative lawsuits
|
|
davos97
|
21 |
5.2K |
11 |
21/10/20 |
21/10/20 |
ASX - By Stock
|
21
|
5.2K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast faces multiple class action lawsuits in the US
|
|
davos97
|
20 |
9.3K |
22 |
21/10/20 |
21/10/20 |
ASX - By Stock
|
20
|
9.3K
|
22
|
|
ASX - By Stock
|
MSB |
Re:
The 'American Rule' and speculative lawsuits
|
|
davos97
|
21 |
5.2K |
25 |
21/10/20 |
21/10/20 |
ASX - By Stock
|
21
|
5.2K
|
25
|
|
ASX - By Stock
|
MSB Biotech |
Re:
WHO Solidarity Trial Results
|
|
davos97
|
45 |
26K |
27 |
17/10/20 |
17/10/20 |
ASX - By Stock
|
45
|
26K
|
27
|
|
ASX - By Stock
|
MSB Biotech |
Re:
WHO Solidarity Trial Results
|
|
davos97
|
45 |
26K |
48 |
17/10/20 |
17/10/20 |
ASX - By Stock
|
45
|
26K
|
48
|
|
ASX - By Stock
|
MSB Biotech |
WHO Solidarity Trial Results
|
|
davos97
|
45 |
26K |
81 |
17/10/20 |
17/10/20 |
ASX - By Stock
|
45
|
26K
|
81
|
|
ASX - By Stock
|
MSB |
Re:
Remdesivir
|
|
davos97
|
10 |
4.8K |
13 |
17/10/20 |
17/10/20 |
ASX - By Stock
|
10
|
4.8K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
davos97
|
13K |
5.0M |
44 |
15/10/20 |
15/10/20 |
ASX - By Stock
|
13K
|
5.0M
|
44
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
davos97
|
9.9K |
3.0M |
4 |
13/10/20 |
13/10/20 |
ASX - By Stock
|
9.9K
|
3.0M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
MPC-06-ID Phase 3 results countdown
|
|
davos97
|
273 |
141K |
1 |
12/10/20 |
12/10/20 |
ASX - By Stock
|
273
|
141K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MPC-06-ID Phase 3 results countdown
|
|
davos97
|
273 |
141K |
3 |
12/10/20 |
12/10/20 |
ASX - By Stock
|
273
|
141K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
legal action Mesoblast Limited Class Action Lawsuit
|
|
davos97
|
36 |
16K |
6 |
12/10/20 |
12/10/20 |
ASX - By Stock
|
36
|
16K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
legal action Mesoblast Limited Class Action Lawsuit
|
|
davos97
|
36 |
16K |
4 |
12/10/20 |
12/10/20 |
ASX - By Stock
|
36
|
16K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
IRENE KRISTAL, I, Plaintiff, v. MESOBLAST LIMITED, SILVIU ITESCU, and JOSH MUNTNER, Defendants.
|
|
davos97
|
223 |
98K |
16 |
12/10/20 |
12/10/20 |
ASX - By Stock
|
223
|
98K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
IRENE KRISTAL, I, Plaintiff, v. MESOBLAST LIMITED, SILVIU ITESCU, and JOSH MUNTNER, Defendants.
|
|
davos97
|
223 |
98K |
9 |
10/10/20 |
10/10/20 |
ASX - By Stock
|
223
|
98K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
IRENE KRISTAL, I, Plaintiff, v. MESOBLAST LIMITED, SILVIU ITESCU, and JOSH MUNTNER, Defendants.
|
|
davos97
|
223 |
98K |
17 |
10/10/20 |
10/10/20 |
ASX - By Stock
|
223
|
98K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
IRENE KRISTAL, I, Plaintiff, v. MESOBLAST LIMITED, SILVIU ITESCU, and JOSH MUNTNER, Defendants.
|
|
davos97
|
223 |
98K |
15 |
10/10/20 |
10/10/20 |
ASX - By Stock
|
223
|
98K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Covid Trial
|
|
davos97
|
9 |
4.6K |
2 |
09/10/20 |
09/10/20 |
ASX - By Stock
|
9
|
4.6K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Conflict of Interest Evidence Thread - C. Hinrichs in ODAC Meeting
|
|
davos97
|
97 |
40K |
9 |
08/10/20 |
08/10/20 |
ASX - By Stock
|
97
|
40K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
davos97
|
13K |
5.0M |
12 |
08/10/20 |
08/10/20 |
ASX - By Stock
|
13K
|
5.0M
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
davos97
|
17K |
6.7M |
3 |
05/10/20 |
05/10/20 |
ASX - By Stock
|
17K
|
6.7M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ruxolitinib vs Ryoncil
|
|
davos97
|
6 |
3.3K |
2 |
05/10/20 |
05/10/20 |
ASX - By Stock
|
6
|
3.3K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ruxolitinib vs Ryoncil
|
|
davos97
|
6 |
3.3K |
23 |
05/10/20 |
05/10/20 |
ASX - By Stock
|
6
|
3.3K
|
23
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
davos97
|
555 |
268K |
60 |
02/10/20 |
02/10/20 |
ASX - By Stock
|
555
|
268K
|
60
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
davos97
|
555 |
268K |
20 |
02/10/20 |
02/10/20 |
ASX - By Stock
|
555
|
268K
|
20
|
|